Guidelines for randomized clinical trial protocol content: a systematic review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2046-4053
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Guidelines for randomized clinical trial protocol content: a systematic review ; volume:1 ; number:1 ; day:24 ; month:9 ; year:2012 ; pages:1-11 ; date:12.2012
Systematic Reviews ; 1, Heft 1 (24.9.2012), 1-11, 12.2012
- Urheber
-
Tetzlaff, Jennifer M.
- Beteiligte Personen und Organisationen
-
Chan, An-Wen
Kitchen, Jessica
Sampson, Margaret
Tricco, Andrea C.
Moher, David
SpringerLink (Online service)
- DOI
-
10.1186/2046-4053-1-43
- URN
-
urn:nbn:de:1111-201607117209
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tetzlaff, Jennifer M.
- Chan, An-Wen
- Kitchen, Jessica
- Sampson, Margaret
- Tricco, Andrea C.
- Moher, David
- SpringerLink (Online service)
Ähnliche Objekte (12)
How can we improve the interpretation of systematic reviews?
Reporting guidelines: doing better for readers
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Reporting guidelines for realist evaluations seek to improve clarity and transparency
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Developing a guideline for clinical trial protocol content: Delphi consensus survey
Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis
Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
How can we improve the interpretation of systematic reviews?
Reporting guidelines: doing better for readers
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Reporting guidelines for realist evaluations seek to improve clarity and transparency
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Developing a guideline for clinical trial protocol content: Delphi consensus survey
Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis
Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
How can we improve the interpretation of systematic reviews?
Reporting guidelines: doing better for readers
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Reporting guidelines for realist evaluations seek to improve clarity and transparency
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Developing a guideline for clinical trial protocol content: Delphi consensus survey
Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis
Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis
Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis